• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球抗菌药物耐药性治理进展及其对中国的启示:综述

The Progress of Global Antimicrobial Resistance Governance and Its Implication to China: A Review.

作者信息

Yin Jia, Wang Yu, Xu Xueran, Liu Yinqi, Yao Lu, Sun Qiang

机构信息

Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Rd, Jinan 250012, China.

NHC Key Laboratory of Health Economics and Policy Research, Shandong University, 44 Wenhuaxi Rd, Jinan 250012, China.

出版信息

Antibiotics (Basel). 2021 Nov 6;10(11):1356. doi: 10.3390/antibiotics10111356.

DOI:10.3390/antibiotics10111356
PMID:34827294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8614673/
Abstract

China has great potential for engaging in global actions on antimicrobial resistance (AMR) control. This study aims to summarize the process of global AMR governance and provide relevant policy recommendations on how China could take more initiative in the global AMR governance. We searched for academic articles and official document published or issued before December 2020 in e-journal databases, official websites of major organizations, and the relevant national ministries. This review revealed that global action on AMR control has experienced three stages: (1) The beginning stage (1980s and 1990s) when actions were mainly sponsored by high-income countries and AMR surveillance was focused on hospitals; (2) The rapid development stage (2000-2010) when global AMR governance began to concentrate on joint actions in multi-sectors, and developing countries were gradually involved in global actions; (3) The comprehensive stage (2011 to present) when global actions on AMR have covered various fields in different countries. China's AMR governance has fallen behind at the beginning but recently began to catch up with the global trend. The central government should take a far-fetched view, act decisively and positively towards the global efforts of addressing AMR to play a more active and greater role on the international stage.

摘要

中国在参与全球抗微生物药物耐药性(AMR)控制行动方面具有巨大潜力。本研究旨在总结全球AMR治理的进程,并就中国如何在全球AMR治理中更积极主动地发挥作用提供相关政策建议。我们在电子期刊数据库、主要组织的官方网站以及相关国家部委的官方网站上搜索了2020年12月之前发表或发布的学术文章和官方文件。本综述表明,全球AMR控制行动经历了三个阶段:(1)起始阶段(20世纪80年代和90年代),行动主要由高收入国家发起,AMR监测主要集中在医院;(2)快速发展阶段(2000 - 2010年),全球AMR治理开始集中于多部门联合行动,发展中国家逐渐参与全球行动;(3)全面阶段(2011年至今),全球AMR行动已涵盖不同国家的各个领域。中国AMR治理起初落后,但最近开始跟上全球趋势。中央政府应高瞻远瞩,对全球应对AMR的努力果断采取积极行动,在国际舞台上发挥更积极、更大的作用。

相似文献

1
The Progress of Global Antimicrobial Resistance Governance and Its Implication to China: A Review.全球抗菌药物耐药性治理进展及其对中国的启示:综述
Antibiotics (Basel). 2021 Nov 6;10(11):1356. doi: 10.3390/antibiotics10111356.
2
Governing antimicrobial resistance: a narrative review of global governance mechanisms.治理抗菌药物耐药性:全球治理机制的叙述性综述。
J Public Health Policy. 2020 Dec;41(4):515-528. doi: 10.1057/s41271-020-00248-9.
3
Moving from assessments to implementation: promising practices for strengthening multisectoral antimicrobial resistance containment capacity.从评估到实施:加强多部门抗菌药物耐药性遏制能力的有效做法
One Health Outlook. 2023 Apr 14;5(1):7. doi: 10.1186/s42522-023-00081-6.
4
The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.抗微生物药物耐药性的全球治理:全球行动计划与国家行动计划一致性的跨国研究。
Global Health. 2020 Nov 11;16(1):109. doi: 10.1186/s12992-020-00639-3.
5
Probing popular and political discourse on antimicrobial resistance in China.探究中国关于抗菌药物耐药性的大众及政治话语。
Glob Health Res Policy. 2019 Feb 28;4:6. doi: 10.1186/s41256-019-0097-z. eCollection 2019.
6
Strengthening multisectoral coordination on antimicrobial resistance: a landscape analysis of efforts in 11 countries.加强抗菌药物耐药性的多部门协调:对11个国家所做努力的全景分析
J Pharm Policy Pract. 2021 Feb 28;14(1):27. doi: 10.1186/s40545-021-00309-8.
7
8
Antimicrobial resistance in China across human, animal, and environment sectors - a review of policy documents using a governance framework.中国人类、动物和环境领域的抗菌药物耐药性——基于治理框架对政策文件的综述
Lancet Reg Health West Pac. 2024 Jun 7;48:101111. doi: 10.1016/j.lanwpc.2024.101111. eCollection 2024 Jul.
9
Policy text analysis of antimicrobial resistance governance in China: A focus on national-level policies.中国抗菌药物耐药治理政策文本分析:以国家级政策为重点
Int J Antimicrob Agents. 2024 Sep;64(3):107286. doi: 10.1016/j.ijantimicag.2024.107286. Epub 2024 Jul 29.
10
Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.评估 15 个非洲国家的国家抗微生物药物耐药性行动计划的透明度和问责制。
Antimicrob Resist Infect Control. 2022 Jan 24;11(1):15. doi: 10.1186/s13756-021-01040-4.

引用本文的文献

1
Antibiotics governance in aquaculture: knowledge, practices, and challenges among stakeholders on the Volta Lake in Ghana.加纳沃尔特湖水产养殖中的抗生素治理:利益相关者的知识、实践与挑战
One Health Outlook. 2025 Apr 11;7(1):22. doi: 10.1186/s42522-025-00141-z.
2
Implementing the Chinese mandatory antimicrobial stewardship program: barriers to continuous improvement.实施中国强制性抗菌药物管理计划:持续改进的障碍
Health Policy Plan. 2025 Jun 12;40(6):591-599. doi: 10.1093/heapol/czaf019.
3
Prevalence, antibiotic resistance, resistance and virulence determinants of in China: A systematic review and meta-analysis.中国[具体内容]的患病率、抗生素耐药性、耐药性和毒力决定因素:一项系统评价和荟萃分析。 (你提供的原文“Prevalence, antibiotic resistance, resistance and virulence determinants of in China”中“of”后面缺少具体描述对象,我按照一般情况补充了“[具体内容]”,你可根据实际情况修改)
One Health. 2025 Feb 10;20:100990. doi: 10.1016/j.onehlt.2025.100990. eCollection 2025 Jun.
4
Infection microenvironment-triggered nanoparticles eradicate MRSA by thermally amplified chemodynamic therapy and M1 macrophage.感染微环境触发的纳米颗粒通过热扩增化学动力学疗法和 M1 巨噬细胞根除耐甲氧西林金黄色葡萄球菌。
J Nanobiotechnology. 2024 Jul 30;22(1):448. doi: 10.1186/s12951-024-02706-y.
5
Antimicrobial resistance in China across human, animal, and environment sectors - a review of policy documents using a governance framework.中国人类、动物和环境领域的抗菌药物耐药性——基于治理框架对政策文件的综述
Lancet Reg Health West Pac. 2024 Jun 7;48:101111. doi: 10.1016/j.lanwpc.2024.101111. eCollection 2024 Jul.
6
Evaluation of the participation of community pharmacists in family planning services: A nonrandomized controlled trial.社区药剂师参与计划生育服务的评估:一项非随机对照试验。
Explor Res Clin Soc Pharm. 2024 Mar 11;14:100430. doi: 10.1016/j.rcsop.2024.100430. eCollection 2024 Jun.
7
Applications and prospects of functional oligosaccharides in pig nutrition: A review.功能性低聚糖在猪营养中的应用与前景:综述
Anim Nutr. 2023 Feb 17;13:206-215. doi: 10.1016/j.aninu.2023.02.002. eCollection 2023 Jun.
8
The prevalence of bovine mastitis-associated in China and its antimicrobial resistance rate: A meta-analysis.中国牛乳腺炎相关疾病的患病率及其抗菌药物耐药率:一项Meta分析。
Front Vet Sci. 2022 Nov 10;9:1006676. doi: 10.3389/fvets.2022.1006676. eCollection 2022.
9
Knowledge, attitude, and practice associated with antimicrobial resistance among medical students between 2017 and 2022: A survey in East China.2017 年至 2022 年间医学生对抗微生物药物耐药性的知识、态度和实践:华东地区的一项调查。
Front Public Health. 2022 Oct 24;10:1010582. doi: 10.3389/fpubh.2022.1010582. eCollection 2022.
10
Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.解析抗微生物药物耐药性政策的多层次治理:以中国广东为例。
Health Policy Plan. 2022 Oct 12;37(9):1148-1157. doi: 10.1093/heapol/czac052.

本文引用的文献

1
Twenty-year trends in antimicrobial resistance from aquaculture and fisheries in Asia.亚洲水产养殖和渔业中抗生素耐药性的 20 年趋势。
Nat Commun. 2021 Sep 10;12(1):5384. doi: 10.1038/s41467-021-25655-8.
2
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study.中国禁止黏菌素阳性添加剂后,动物源和人源大肠杆菌中黏菌素耐药性和 mcr-1 丰度的变化:一项流行病学比较研究。
Lancet Infect Dis. 2020 Oct;20(10):1161-1171. doi: 10.1016/S1473-3099(20)30149-3. Epub 2020 Jun 4.
3
Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal study.评估中国社区药店中非处方抗生素配药情况:一项混合横断面和纵向研究。
Lancet Infect Dis. 2019 Dec;19(12):1345-1354. doi: 10.1016/S1473-3099(19)30324-X. Epub 2019 Oct 3.
4
Detection and Quantitation of Lomefloxacin and Pefloxacin Residues in the Organ Tissues and Eggs of Laying Hens.蛋鸡器官组织及蛋中洛美沙星和培氟沙星残留的检测与定量分析
J Food Prot. 2018 May;81(5):810-814. doi: 10.4315/0362-028X.JFP-17-422.
5
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.2000 年至 2015 年间,抗生素消费在全球范围内增长,并在地理上趋同。
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470. doi: 10.1073/pnas.1717295115. Epub 2018 Mar 26.
6
Antibiotic consumption in Shandong Province, China: an analysis of provincial pharmaceutical centralized bidding procurement data at public healthcare institutions, 2012-16.中国山东省抗生素消费情况分析:2012-2016 年公立医疗机构药品集中招标采购数据分析。
J Antimicrob Chemother. 2018 Mar 1;73(3):814-820. doi: 10.1093/jac/dkx469.
7
Antimicrobial resistance and universal health coverage.抗微生物药物耐药性与全民健康覆盖
BMJ Glob Health. 2017 Oct 31;2(4):e000518. doi: 10.1136/bmjgh-2017-000518. eCollection 2017.
8
Elevated antimicrobial residues in animal food products call for institutional changes on veterinary drug management and animal food product surveillance in China.动物食品中抗菌药物残留量升高,要求中国在兽药管理和动物食品监管方面进行制度变革。
Int J Antimicrob Agents. 2018 Jan;51(1):165-166. doi: 10.1016/j.ijantimicag.2017.11.016. Epub 2017 Nov 29.
9
Review of antibiotic resistance in China and its environment.中国抗生素耐药性及其环境综述。
Environ Int. 2018 Jan;110:160-172. doi: 10.1016/j.envint.2017.10.016. Epub 2017 Oct 27.
10
Effect of a training and educational intervention for physicians and caregivers on antibiotic prescribing for upper respiratory tract infections in children at primary care facilities in rural China: a cluster-randomised controlled trial.中国农村基层医疗保健机构的医生和照护人员培训教育干预对儿童上呼吸道感染抗生素处方的影响:一项整群随机对照试验。
Lancet Glob Health. 2017 Dec;5(12):e1258-e1267. doi: 10.1016/S2214-109X(17)30383-2. Epub 2017 Nov 5.